AMETEK, Inc. AME
Composite 54/100; the shares have moved about 26% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 24/100 — a strong mark against it.
Balance-sheet strength ranks 72/100 — a moderate point in its favour. Quality ranks 63/100 — a moderate point in its favour. Momentum ranks 60/100 — a slight point in its favour.
Valuation ranks 24/100 — a strong mark against it. Income ranks 38/100 — a slight mark against it. Growth ranks 50/100 — a slight mark against it.
What the company does AMETEK designs and makes electronic instruments and electromechanical devices for process, aerospace, power, medical, and industrial markets through its EIG and EMG segments.
Key financials AMETEK posts ROE 14.6%, ROA 8.2%, and ROCE 14.4%, with gross, operating, and net margins of 36.9%, 26.2%, and 20.0%. Revenue and EPS growth are 6.6% and 8.0%, supported by strong profitability metrics.
Stock health Quality score 63.3 and strength score 72.3 indicate solid fundamentals, while momentum score 60.0 and RSI 34.80 suggest recent weakness. The Piotroski F-Score is 6/9 and Altman Z is 8.17, signaling moderate financial health.
Price vs fair value The stock trades at a discount of 20.00% versus the analyst mean target of 277.50. - Forward P/E 31.35 is high versus historical norms (Valuation 24.3/100) - PEG ratio 2.32 suggests growth is priced at a premium - Net margins 20.0% are strong but valuation multiples remain elevated
Looking forward Forward revenue growth of 6.6% and EPS growth of 8.0% underpin steady demand across end-markets, though valuation metrics remain rich relative to quality scores.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.